4/A

PRIMARY DOCUMENT

Company: Aquestive Therapeutics, Inc.
Filed: February 26, 2020
Period of Report: December 31, 2019
Accession Number: 0001214659-20-001882

View Document ↗ View on SEC.gov ↗